Market revenue in 2023 | USD 486.0 million |
Market revenue in 2030 | USD 668.5 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Goat |
Fastest growing segment | Mouse |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Goat, Rabbit, Horse, Mouse |
Key market players worldwide | Abcam PLC, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Novartis AG ADR, Merck KGaA, New England Biolabs, Stemcell Holdings Inc Ordinary Shares, Phoenix Group Holdings PLC, G-Biosciences, Roche Holding AG |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mammalian polyclonal igg antibody market will help companies and investors design strategic landscapes.
Goat was the largest segment with a revenue share of 19.86% in 2023. Horizon Databook has segmented the North America mammalian polyclonal igg antibody market based on goat, rabbit, horse, mouse covering the revenue growth of each sub-segment from 2018 to 2030.
North America comprises the U.S. and Canada, which accounted for USD 292.4 million in 2017. Increasing number of R&D activities by biotechnological & pharmaceutical companies is expected to drive growth of this market.
Presence of key market players in this region, which are undertaking strategic initiatives such as new product development and merger & acquisitions, is expected to generate lucrative market growth opportunities in this region.
Rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune diseases among others are some major factors propelling market growth in the region. According to the World Health Organization, noncommunicable diseases such as chronic respiratory disorders, cardiovascular disorders, cancer, and diabetes contributed to 71% of the total deaths in 2017.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America mammalian polyclonal igg antibody market , including forecasts for subscribers. This continent databook contains high-level insights into North America mammalian polyclonal igg antibody market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account